Melatonin

Melatonin is a naturally occurring neurohormone synthesized by the pineal gland that regulates circadian rhythms and the sleep-wake cycle. It acts as a chronobiotic, antioxidant, and anti-inflammatory agent, with supplemental forms used primarily to improve sleep onset and quality. Melatonin levels decline with age and can be affected by various physiological conditions and environmental factors.

Overview

Melatonin (N-acetyl-5-methoxytryptamine) is a phylogenetically ancient molecule produced primarily by the pineal gland in response to darkness, serving as the master chronobiological signal that synchronizes circadian rhythms with the light-dark cycle. Synthesized from tryptophan via serotonin through the sequential actions of arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT), melatonin acts on MT1 and MT2 G-protein-coupled receptors in the suprachiasmatic nucleus (SCN) of the hypothalamus to modulate the circadian clock. Beyond its chronobiotic role, melatonin is one of the most potent endogenous antioxidants known, with the ability to directly scavenge hydroxyl radicals, peroxynitrite, and singlet oxygen while also upregulating antioxidant enzymes (superoxide dismutase, glutathione peroxidase, catalase) and downregulating pro-oxidant enzymes.

As a sleep aid, melatonin is one of the most widely used supplements globally, with robust evidence supporting its efficacy for reducing sleep onset latency (by approximately 7–12 minutes on average across meta-analyses), improving subjective sleep quality, and resynchronizing disrupted circadian rhythms in jet lag, shift work, and delayed sleep-wake phase disorder. Exogenous melatonin at physiological doses (0.3–1 mg) is most effective as a chronobiotic when timed 1–2 hours before desired sleep onset, while pharmacological doses (3–10 mg) are commonly used for their mild hypnotic and anxiolytic effects. Prolonged-release formulations better mimic the endogenous secretion profile and are particularly beneficial for sleep maintenance in older adults, who often exhibit diminished natural melatonin production.

The therapeutic scope of melatonin extends considerably beyond sleep. It demonstrates significant anti-inflammatory activity through suppression of NF-kB, NLRP3 inflammasome inhibition, and modulation of pro-inflammatory cytokines. Oncological research has identified melatonin as an anti-cancer agent that inhibits tumor proliferation, angiogenesis, and metastasis through multiple mechanisms including epigenetic modulation, immune surveillance enhancement, and circadian gene regulation. Melatonin also shows neuroprotective effects in neurodegenerative disease models and has been studied for migraine prophylaxis, IBS, tinnitus, and perioperative anxiety. It synergizes well with magnesium glycinate, magnolia bark, and glycine in comprehensive sleep protocols. Side effects are generally mild (next-day grogginess, vivid dreams) and melatonin has an exceptionally wide therapeutic index with no established lethal dose in humans.

Mechanism of Action

Melatonin (N-acetyl-5-methoxytryptamine) is an indoleamine neurohormone synthesized from serotonin in the pineal gland that acts through both receptor-dependent and receptor-independent mechanisms. Its primary actions are mediated by two G protein-coupled receptors: MT1 (MTNR1A) and MT2 (MTNR1B). MT1 receptors, coupled to Gi/o proteins, inhibit adenylyl cyclase and reduce cAMP/PKA signaling in the suprachiasmatic nucleus (SCN) of the hypothalamus, acutely suppressing neuronal firing to promote sleep onset. MT1 also activates phospholipase C-beta through Gq coupling in certain tissues, mobilizing intracellular calcium. MT2 receptors, primarily expressed in the SCN and retina, phase-shift circadian rhythms by modulating the molecular clock machinery—specifically the transcription-translation feedback loops involving CLOCK, BMAL1, PER, and CRY genes.

Independent of receptor activation, melatonin functions as a potent direct free radical scavenger, neutralizing hydroxyl radicals, peroxyl radicals, singlet oxygen, and peroxynitrite through electron donation from its indole ring system. Each melatonin molecule can scavenge up to 10 reactive oxygen/nitrogen species through a cascade of metabolites (cyclic 3-hydroxymelatonin, AFMK, AMK) that themselves retain antioxidant activity. Melatonin also upregulates antioxidant enzyme expression—including superoxide dismutase, glutathione peroxidase, and catalase—through Nrf2/ARE pathway activation, while simultaneously inhibiting pro-oxidant enzymes such as nitric oxide synthase and lipoxygenase.

Additional mechanisms include immunomodulation through MT1/MT2 receptors on T lymphocytes and NK cells, enhancing IL-2 and IFN-gamma production while suppressing excessive inflammatory responses. Melatonin stabilizes mitochondrial membrane potential, inhibits mitochondrial permeability transition pore (mPTP) opening, and enhances electron transport chain efficiency at Complex I and Complex IV. These pleiotropic actions support its therapeutic roles in circadian rhythm disorders, insomnia, neurodegeneration, cancer adjunctive therapy, and cardiovascular protection.

Reconstitution Calculator

Research

Safety Profile

Common side effects include dizziness, headache, nausea, and daytime drowsiness. It may not be suitable for pregnant or breastfeeding women, individuals with autoimmune diseases, or those taking certain medications. Melatonin can interact with blood thinners, anticonvulsants, and blood pressure medications, so consultation with a healthcare provider is recommended.

Pharmacokinetic Profile